Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

Joseph K. Wong, Marjan Hezareh, Huldrych F. Günthard, +4

Science

Viral LatencyViral PersistenceHuman RetrovirusReplication-competent HivImmunology +11

Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1

Marjan Hezareh, Ann J. Hessell, Richard Christian Jensen, +2

Journal of Virology

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

Arto A. Palmu, Jukka Jokinen, Dorota Borys, +9

The Lancet

VaccinationInvasive Pneumococcal DiseaseVaccine DevelopmentImmunologyVaccine Efficacy +3

Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy

Huldrych F. Günthard, Simon D. W. Frost, Andrew Brown, +9

Journal of Virology

Potent Antiviral TherapyImmunologyAntiviral DrugHuman Immunodeficiency VirusImmunotherapy +14

Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study

Lynette Denny, Bronwyn Hendricks, Chivaugn Gordon, +6

Vaccine

Intravaginal Practices and Risk of Bacterial Vaginosis and Candidiasis Infection Among a Cohort of Women in the United States

Joelle Brown, Kristen L. Hess, Stephen J. Brown, +3

Obstetrics and Gynecology

Effectiveness of the 10-Valent Pneumococcal Nontypeable<i>Haemophilus influenzae</i>Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland

Timo Vesikari, Aino Forstén, Ilkka Seppä, +10

Journal of the Pediatric Infectious Diseases Society

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial

Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim, +14

Human Vaccines & Immunotherapeutics

Mechanisms of HIV Receptor and Co-Receptor Down-Regulation by Prostratin: Role of Conventional and Novel PKC Isoforms

Marjan Hezareh, Moulay Ahmed Moukil, Ildikó Szántó, +6

Antiviral chemistry & chemotherapy

ImmunologyMolecular BiologyHiv ReceptorDistinct Pkc IsoformsCo-receptor Down-regulation +17

Prostratin Induces HIV Activation and Downregulates HIV Receptors in Peripheral Blood Lymphocytes

Joaquín Rullás, Mercedes Bermejo, Javier García‐Pérez, +5

Antiviral Therapy

Viral ReplicationImmunologyImmune RegulationImmunodominanceImmune System +20